Healthy male adults
Conditions
Interventions
Consumption of the test beverage (500 mL) to the subject before starting the measurement of respiratory metabolism.
Consumption of the placebo beverage (500 mL) to the subject before starting the mea
Sponsors
CPCC Company Limited
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: (1) Healthy male subjects ranging in age from 20 to 39. (2) Subjects who do not have a habit of exercises. (3) Subjects ranging in BMI from 18.5 to less than 25.0 kg/m2. (4) Subjects who can give informed consent to take part in this trial after being provided with an explanation of the protocol detail.
Exclusion criteria
Exclusion criteria: (1) Subjects with previous and/or current medical history of serious diseases in circulatory/respiratory/digestive/urinary organs. (2) Throughout this trial, subjects who have any difficulty in refraining from taking steadily in the medicines (related to blood pressure, fatigue, lipid, and/or allergic rhinitis), which might affect the test results. (3) Subjects taking steadily in the following foods that might affect their test result; health-specific, functional, health foods (related to blood pressure, blood stream, exercise fatigue, metabolism-improving, poor blood flow-improving, fat combustion and/or lipolysis), supplementary one, vitamin tablet and nutrient, with any difficulty in refraining from having those during this trial. (4) Subjects who take excessive alcohol. (5) Subjects with any possibility of hindrance to this trial, owing to their allergic rhinitis. (6) Subjects who are now under the other clinical tests with some kind of medicine/food, or participated in those tests within four weeks before this trial. (7) Subjects falling into the habit of smoking. (8) Subjects suffering from severe anemia. (9) Subjects having drug and/or food allergy. (10) Subjects who donated over 200 mL of their whole blood and/or blood components within a month before this trial. (11) Subjects who donated over 400 mL of their whole blood within the last three months before this trial. (12) Subjects who will be collected over 1200 mL of their blood within the last twelve months before this trial. (13) Others who have been determined as ineligible for participation, judging from the principal/sub investigator's opinions.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Respiratory quotient | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Fat oxidation amount 2. Energy expenditure level | — |
Countries
Japan
Contacts
Public ContactMakoto Ichinohe
CPCC Company Limited Clinical Planning Department
Outcome results
None listed